About Schott Pharma India Private Limited
Data last updated:
Schott Pharma India Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 21 December 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U26100MH1994PTC083938. Its GSTIN is 27AAACK2310G2Z2 (Maharashtra). The company holds 7 GST registrations, of which 5 are active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹32.21 Lakh. It was formerly known as Schott Kaisha Private Limited and Kaisha Manufacturers Private Limited. It is led by directors including Roy Joseph Manicknaparambil (Managing Director) and Soumitra Bhattacharyya.
Its last annual general meeting (AGM) was held on 29 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,056.41 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹221.8 Cr (net margin 21%) and EBITDA of ₹383.91 Cr (EBITDA margin 36.3%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 12% over five years.
The company has about 1,372 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: SCHOTT Poonawalla. As per MCA filings, the company has open charges of ₹349 Cr and satisfied charges of ₹839.88 Cr on record. Court records list 19 cases involving the company, including 13 filed by the company and 6 filed against it; 1 case is pending. The company has 7 deals on record (5 secondary share transfers, 2 funding rounds), with disclosed funding of ₹34.2 Lakh; the latest was in May 2025. The company has 16 MSME Form 1 returns on record between 2013 and 2024, listing 808 overdue payments to 73 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website schott-poonawalla.com.
Company details
Name history
Schott Pharma India has undergone 2 name changes throughout its history. The company was previously known as Schott Kaisha Private Limited, and Kaisha Manufacturers Private Limited. The current legal name is Schott Pharma India Private Limited.
| Company Name | Status |
|---|---|
| Schott Pharma India Private Limited | Current |
| Schott Kaisha Private Limited | Previous |
| Kaisha Manufacturers Private Limited | Previous |
Contact details
Schott Pharma India Private Limited's registered office is in Mumbai, Maharashtra. Its website is schott-poonawalla.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUnit No. 401 Wing 1 4th Floor Corporate Avenue Building, Village Chakala Ward – K/East Andheri (East), Mumbai, Maharashtra, India – 400093
- IndustryHealthcare, Medical Consumables & Supplies
To see the full contact details of Schott Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Schott Pharma India operates one associated brand: SCHOTT Poonawalla. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Packaging solutions for pharmaceutical and biotech industries are provided. | schott-poonawalla.com |
Business activity
The main business activity of Schott Pharma India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Schott Pharma India Private Limited, buy the company report.
Financials of Schott Pharma India Private Limited
FY 2025 filings availableSchott Pharma India Private Limited reported revenue of ₹1,056.41 Cr (up 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 12% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1,056.41 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹383.91 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹221.8 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 36.3% | ||||
| Net Profit Margin | 21% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Schott Pharma India Private Limited, buy the company report.
Board of directors of Schott Pharma India Private Limited
Schott Pharma India has 7 current directors and 23 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Fabian Stoecker | Additional Director | 15 Dec 2025 | 0 Years 10 Months | Current |
| Soumitra Bhattacharyya | Director | 13 May 2025 | 1 Years 5 Months | Current |
| Mahadevan Narayanamoni | Director | 13 May 2025 | 1 Years 5 Months | Current |
| Bhushan Sudhir Bopardikar | Director | 13 May 2025 | 1 Years 5 Months | Current |
| Reinhard Josef Mayer | Additional Director | 07 Sep 2026 | 0 Years 1 Months | Current |
| Dr Christian Alexander Mias | Additional Director | 24 Aug 2026 | 0 Years 2 Months | Current |
Auditor
Schott Pharma India Private Limited is audited by S R B C & CO LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R B C & CO LLP | FY 2022 | 324982E/E300003 |
Shareholding
The shareholding of Schott Pharma India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Schott Pharma India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Mar 2019 | 100251449 | Others | ₹35 Cr | Open | |
| 29 Jan 2018 | 100163903 | Hdfc Bank Limited | ₹20 Cr | Open | |
| 28 Nov 2017 | 100140111 | Citi Bank N.A. | ₹35 Cr | Open | |
| 22 May 2012 | 10364582 | Others | ₹88 Cr | Open | |
| 11 Jan 2012 | 10339431 | Others | ₹133 Cr | Open |
To see the full charge records of Schott Pharma India Private Limited, buy the company report.
Total charge records: 43 View all charges
Deals & funding
Schott Pharma India Private Limited has 7 deals on record (5 secondary share transfers, 2 funding rounds), with disclosed funding of ₹34.2 Lakh; the latest was in May 2025.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2025 | Secondary share transfer | Undisclosed | Buyer: TPG Capital India, Novo Holdings Seller: Serum Institute of India Private Limited |
| Jun 2023 | Secondary share transfer | Undisclosed | Buyer: Schott Pharma Schweiz AG Seller: Schott Glaswerke Beteiligungs-und Export GmbH |
| Aug 2021 | Secondary share transfer | Undisclosed | Buyer: Serum Institute of India Private Limited Seller: 2 individuals |
| Apr 2012 | Secondary share transfer | Undisclosed | Buyer: Schott Glaswerke Beteiligungs-und Export GmbH Seller: Schott Pharmaceutical Packaging GmbH |
| Jun 2010 | Funding round | ₹2 Lakh | Investors: Schott Pharmaceutical Packaging GmbH, 2 individuals |
To see the full deal history of Schott Pharma India Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Schott Pharma India Private Limited has 19 court cases on record: 13 filed by Schott Pharma India, 6 filed against it. 1 case is pending and 18 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 4 | 1 |
| High courts | 9 | 2 | 0 |
Cases on record (5 of 19)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (O.M.P.(I) (COMM.)) | Filed against the company by Precast India Infrastructures Pvt. Ltd. | Disposed |
| Bombay High Court | Appeal | Filed against the company by Sriguru Credit Capital Services Ltd. | Disposed |
| Bombay High Court | Company petition | Filed by the company against Sriguru Credit Capital Services Ltd. Cin No. U65921mh1995plc084440 | Disposed |
| Bombay High Court | Company petition | Filed by the company against Shreya Life Sciences Pvt. Ltd. Cin No. U51900mh1991ptc061136 | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Cases SS) | Filed by the company against M-S.Shreechem Pharmaceuticals Pvt.Ltd. | Disposed |
To see the full case history of Schott Pharma India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Schott Pharma India Private Limited has 16 MSME Form 1 returns on record between 2013 and 2024, listing 808 overdue payments to 73 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 73)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Ryder Shipping Lines Private Limited | |||
| Kairish Innotech Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| Evolve Aqua Solutions LLP |
To see the full MSME payment records of Schott Pharma India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Schott Pharma India Private Limited has a workforce of 1,372 employees on its EPFO records as of Mar 21, 2024, across 1 active EPFO establishment.
GST
Schott Pharma India has 7 GST registrations: 5 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACK2310G2Z2 | Maharashtra | Active | 27 Jul 2017 |
| 27AAACK2310G3Z1 | Maharashtra | Active | 25 Nov 2021 |
| 24AAACK2310G1Z9 | Gujarat | Active | 01 Jul 2017 |
| 02AAACK2310G1ZF | Himachal Pradesh | Active | 10 Sep 2019 |
To see the full GST registrations and return filing status of Schott Pharma India Private Limited, buy the company report.
Recent activity
Schott Pharma India Private Limited has 30 board changes on record since 2008: 7 appointments and 23 cessations. The latest: Reinhard Josef Mayer was appointed as Additional Director on 07 Sep 2026.
116 earlier events are in the company report.
News
Frequently asked questions
Schott Pharma India is an active private limited company based in Mumbai, Maharashtra, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 21 December 1994 (32+ years old) and is registered under CIN U26100MH1994PTC083938.
Schott Pharma India has 7 current directors:
- Roy Joseph Manicknaparambil - Managing Director
- Fabian Stoecker - Additional Director
- Soumitra Bhattacharyya - Director
- Mahadevan Narayanamoni - Director
- Bhushan Sudhir Bopardikar - Director
- Reinhard Josef Mayer - Additional Director
- Dr Christian Alexander Mias - Additional Director
The latest financial statements of Schott Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Schott Pharma India is 27AAACK2310G2Z2, registered in Maharashtra. The company has 7 GST registrations in all, of which 5 are active and 2 are cancelled or inactive. Other active GSTINs include 27AAACK2310G3Z1 (Maharashtra), 24AAACK2310G1Z9 (Gujarat), 02AAACK2310G1ZF (Himachal Pradesh).
The CIN (Corporate Identification Number) of Schott Pharma India is U26100MH1994PTC083938. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Schott Pharma India has 19 court cases on record: 13 filed by the company and 6 filed against it. 1 is pending. Most are in the district courts.
Schott Pharma India was incorporated on 21 December 1994, making it 32+ years old. It is registered with the Registrar of Companies, Mumbai.
Schott Pharma India has 7 deals on record (5 secondary share transfers, 2 funding rounds), with disclosed funding of ₹34.2 Lakh; the latest was in May 2025.
Reinhard Josef Mayer was appointed as Additional Director on 07 Sep 2026. Dr Christian Alexander Mias was appointed as Additional Director on 24 Aug 2026. Roy Joseph Manicknaparambil was appointed as Managing Director on 01 Jul 2026. Schott Pharma India has 30 board changes on record in total.
Schott Pharma India has 16 MSME Form 1 returns on record between 2013 and 2024, listing 808 overdue payments to 73 micro and small suppliers. The latest return was filed on 22 Apr 2024.
Schott Pharma India can be reached through the website schott-poonawalla.com. Its registered office is in Mumbai, Maharashtra, India.